Noxilizer Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$30M
- Investors
-
2
Noxilizer General Information
Description
Developer of nitrogen dioxide sterilization technology designed to facilitate pharmaceutical and biotech manufacturing. The company's technology utilizes ultra-low temperature processing, low-pressure mechanisms, and rapid cycle times to provide terminal sterilization, material compatibility, and protein integrity preservation, enabling pharmaceutical and medical device manufacturers to protect temperature-sensitive drug-device combination products and accelerate batch release timelines.
Contact Information
Website
www.noxilizer.comCorporate Office
- 1334 Ashton Road
- Suite E
- Hanover, MD 21076
- United States
Corporate Office
- 1334 Ashton Road
- Suite E
- Hanover, MD 21076
- United States
Noxilizer Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 10-Sep-2025 | $30M | Completed | Generating Revenue | ||
| 13. Secondary Transaction - Private | 01-Sep-2022 | Completed | Generating Revenue | |||
| 12. Secondary Transaction - Private | 01-Mar-2021 | Completed | Generating Revenue | |||
| 11. Debt - PPP | 11-Apr-2020 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 03-Apr-2014 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 03-Sep-2013 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 01-Jan-2013 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 21-Nov-2012 | Completed | Generating Revenue | |||
| 6. Grant | 07-Sep-2012 | $500K | $18.2M | Completed | Generating Revenue | |
| 5. Later Stage VC | 22-Oct-2010 | $5.67M | $18.2M | Completed | Generating Revenue |
Noxilizer Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C3 | ||||||||
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B4 | ||||||||
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | 11,200,000 | $0.010000 | 8% | $0.63 | $1.26 | $0.63 | 22.32% | |
| Series A | 11,000,000 | $0.010000 | 6% | $0.72 | $0.72 | $0.72 | 21.93% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Noxilizer Comparisons
Industry
Financing
Details
Noxilizer Competitors (11)
One of Noxilizer’s 11 competitors is Hartmann (Medical Supplies), a Corporation company based in Rio de Janeiro, Brazil.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hartmann (Medical Supplies) | Corporation | Rio de Janeiro, Brazil | ||||
| Becton, Dickinson and Company | Corporation | Franklin Lakes, NJ | ||||
| Wassenburg Medical | Corporate Backed or Acquired | Elst, Netherlands | ||||
| Sotera Health | Formerly PE-Backed | Broadview Heights, OH | ||||
| Steelco | Corporate Backed or Acquired | Riese Pio X, Italy |
Noxilizer Patents
Noxilizer Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260083871-A1 | Sterilization methods | Pending | 24-Sep-2024 | ||
| WO-2026072672-A1 | Sterilization methods | Pending | 24-Sep-2024 | ||
| US-20260085269-A1 | Sterilization process challenge devices | Pending | 24-Sep-2024 | ||
| WO-2026072720-A1 | Sterilization process challenge devices | Pending | 24-Sep-2024 | ||
| US-12708681-B2 | Method of sterilization specimen conditioning | Active | 14-Jun-2022 | A61L2/06 |
Noxilizer Signals
Noxilizer Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NewVale Capital | Growth/Expansion | Minority | ||
| VisionTech Partners | Angel Group | Minority |
Noxilizer Acquisitions (1)
Noxilizer’s most recent deal was a Merger/Acquisition with SAIAN. The deal was made on 01-Feb-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SAIAN | 01-Feb-2013 | Merger/Acquisition | Other Devices and Supplies |
Noxilizer FAQs
-
When was Noxilizer founded?
Noxilizer was founded in 2004.
-
Where is Noxilizer headquartered?
Noxilizer is headquartered in Hanover, MD.
-
What is the size of Noxilizer?
Noxilizer has 42 total employees.
-
What industry is Noxilizer in?
Noxilizer’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Noxilizer a private or public company?
Noxilizer is a Private company.
-
What is Noxilizer’s current revenue?
The current revenue for Noxilizer is .
-
How much funding has Noxilizer raised over time?
Noxilizer has raised $61.5M.
-
Who are Noxilizer’s investors?
NewVale Capital and VisionTech Partners have invested in Noxilizer.
-
Who are Noxilizer’s competitors?
Hartmann (Medical Supplies), Becton, Dickinson and Company, Wassenburg Medical, Sotera Health, and Steelco are some of the 11 competitors of Noxilizer.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process